skip to content

Cambridge Immunology Network

 
Read more at: Professor Lalita Ramakrishnan elected Fellow of The Royal Society
Professor Lalita Ramakrishnan elected Fellow of The Royal Society

Professor Lalita Ramakrishnan elected Fellow of The Royal Society

10 May 2018

Lalita Ramakrishnan is the Professor of Immunology and Infectious Diseases in the Department of Medicine, University of Cambridge and has been elected Fellow of the Royal Society (2018). She studies tuberculosis disease pathogenesis in the zebrafish. The zebrafish is genetically tractable and optically transparent enabling the manipulation and monitoring of infection in real-time. The use of the zebrafish has led to surprising discoveries about TB that have immediate clinical implications.


Read more at: Typhoid outbreak: genetic cause of extensive drug resistance found

Typhoid outbreak: genetic cause of extensive drug resistance found

20 February 2018

The results suggest that treatment options for typhoid treatment are running out and preventative strategies are needed. “We have used genetic sequencing to uncover how this particular strain of typhoid became resistant to several key antibiotics. Sporadic cases of typhoid with these levels of antimicrobial resistance have been seen before, but this is the first time we’ve seen an ongoing outbreak – which is concerning.” Professor Gordon Dougan, a senior author from the Wellcome Sanger Institute and University of Cambridge Department of Medicine


Read more at: The Borysiewicz Biomedical Sciences Fellowship Programme

The Borysiewicz Biomedical Sciences Fellowship Programme

22 January 2018

Application deadline: 17:00 on Monday 26 February 2018. The Borysiewicz Biomedical Sciences Fellowships have been developed in honour of Sir Leszek Borysiewicz, a pioneer in the biomedical sciences, who when Vice-Chancellor of the University led and shaped the development of key provisions for Cambridge’s postdoc community.


Read more at: Patrick Sissons Evelyn Trust Research Fellowship in Infection and Immunity

Patrick Sissons Evelyn Trust Research Fellowship in Infection and Immunity

22 January 2018

In memory of Professor Sir Patrick Sissons MD, FRCP, FRCPath, FMedSci. (1945-2016), Darwin College is seeking to elect a stipendiary Research Fellow. Patrick Sissons was the leader of the University of Cambridge’s Clinical School as Regius Professor of Physic (2005–2012) following his service as Head of the Department of Medicine (1993-2005).


Read more at: Computer-designed antibodies target toxins associated with Alzheimer’s disease

Computer-designed antibodies target toxins associated with Alzheimer’s disease

23 June 2017

Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production.


Read more at: The bug hunters and the microbiome

The bug hunters and the microbiome

23 June 2017

Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind. The bugs they collect are invisible to the naked eye. And even though we’re teeming with them, researchers are only beginning to discover how they keep us healthy – and how we could use these bugs as drugs.


Read more at: Professor Arthur Kaser- Congratulations to our new Academy of Medical Sciences Fellow

Professor Arthur Kaser- Congratulations to our new Academy of Medical Sciences Fellow

9 May 2017

46 world leading UK researchers have been elected to the prestigious Fellowship of the Academy of Medical Sciences.


Read more at: Dr Andrew McKenzie- Congratulations to our new Royal Society Fellow

Dr Andrew McKenzie- Congratulations to our new Royal Society Fellow

5 May 2017

Dr Andrew McKenzie FMedSci FRS Fellow Elected: 2017


Read more at: Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute
Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute

8 January 2017

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute, has received funding from Cambridge Innovation Capital (CIC) and IP Group to use the latest discoveries in the characterisation of our bacteria and their role in health and disease to develop bacteriotherapy - a radical way to treat disease based on using the bacteria themselves.


Read more at: Cancer Research UK - Immunology call

Cancer Research UK - Immunology call

22 October 2016

At Cancer Research UK we recognise that immunology has underpinned some of the most exciting discoveries in modern cancer research. We are committed to supporting cutting-edge immunology to deepen our understanding of the interactions between the immune system and tumours.